Dalrada Health’s Empower Genomics Receives CDC Approval and Funding for Vaccine Initiative

Local, state, and federal approval enables Dalrada subsidiary to distribute and administer COVID-19 vaccines as Empower Genomics continues to join forces with government agencies to combat the ongoing pandemic.

Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada”), a problem-solving innovator that takes on complex, multi-disciplinary challenges in health care, clean energy, precision manufacturing, and technology, announced today that Dalrada Health’s Empower Genomics vaccine program received approval by the Centers for Disease Control and Prevention (CDC).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221207005362/en/

Dalrada Health’s Empower Genomics logo.

Driven by Empower Genomics team member, Julia Zavala, this accomplishment puts the Dalrada Health subsidiary on equal footing with large pharmacies and drug store chains in regard to the distribution and administration of vaccines to at-risk populations within the greater San Diego area. Empower Genomics now delivers Influenza (Flu) and COVID-19 vaccines to long term care facilities, infants and toddlers, and the general public through community sites and mobile clinics.

“Empower Genomics and Dalrada Health are deeply committed to health and wellness,” said Harvey Hershkowitz, President of Dalrada Health. “The ability to administer and distribute potential life-saving vaccines is a major milestone in our efforts to protect our community while helping to stop the spread of highly-contagious viruses and diseases.”

The state of California has issued Empower Genomics grant funding to continue its efforts in aiding the community at large. Empower Genomics is proud …

Full story available on Benzinga.com

manufacturing
genomics
vaccines
wellness
mobile